NEXTBio Capital Management LP
CIK 2038158 · 在 SEC EDGAR 上查看 ↗
- 投资组合价值
- $217.4M
- 持仓
- 22
- 截至
- 2026年6月30日
按 13F 价值排名第 6174（共 9443） · 前 65.4%
投资组合价值同比（季度）：+0.9% 13F不披露现金
- 前十大持仓权重
- 77.70%
- 前二十五大持仓权重
- 100.00%
- 持仓高于 1%
- 20
- 有效持仓数量
- 13.5
仅基于13F多头股票持仓（现金、债券、空头未披露）
周转率 Q2 2026: 13.02% 估计买入 $28175236 · 卖出 $52334652
- 新仓位
- 3
- 增加
- 7
- 减少
- 5
- 已结清
- 5
本页内容
行业细分
Healthcare
100.0%
完整投资组合 22 持仓
| 类型 | 连胜 | 8个季度趋势 | |||||
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, Inc. - Common Stock | $26885839 | 12.37% | 219333 | $2683996 | 下跌 ×1 | ||
| STTK Shattuck Labs, Inc. - Common Stock | $25867795 | 11.90% | 3727348 | $5613893 | 上涨 ×1 | ||
| CMPS COMPASS Pathways Plc - American Depository Shares | $25126990 | 11.56% | 1775759 | $13948609 | 下跌 ×1 | ||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $16771660 | 7.71% | 312496 | $10349540 | 上涨 ×2 | ||
| VOR Vor Biopharma Inc. - Common Stock | $16369509 | 7.53% | 889164 | $-1469902 | 下跌 ×1 | ||
| RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | $14629091 | 6.73% | 131758 | $3664087 | 上涨 ×2 | ||
| PVLA Palvella Therapeutics, Inc. - Common Stock | $13739893 | 6.32% | 89909 | $3433083 | 上涨 ×1 | ||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $11059461 | 5.09% | 183225 | $404927 | |||
| ZBIO Zenas BioPharma, Inc. - Common Stock | $10830560 | 4.98% | 426736 | $2487871 | |||
| ORIC Oric Pharmaceuticals, Inc. - Common Stock | $7647323 | 3.52% | 706124 | $1013070 | 上涨 ×1 | ||
| IVA Inventiva S.A. - American Depository Shares | $6758580 | 3.11% | 1787984 | $-642256 | 上涨 ×2 | ||
| CBIO Crescent Biopharma, Inc. - Common Stock | $6711408 | 3.09% | 372856 | $-137957 | |||
| PCVX Vaxcyte, Inc. - Common Stock | $6232873 | 2.87% | 107223 | $699464 | 上涨 ×1 | ||
| COGT Cogent Biosciences, Inc. - Common Stock | $5072603 | 2.33% | 131075 | $23177 | 下跌 ×1 | ||
| VSTM Verastem, Inc. - Common Stock | $4991976 | 2.30% | 1306800 | $-1934064 | |||
| IRON Disc Medicine, Inc. - Common Stock | $3851187 | 1.77% | 52655 | $484426 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $3736542 | 1.72% | 108055 | 上涨 ×1 | |||
| ZLAB Zai Lab Limited - American Depositary Shares | $3483878 | 1.60% | 183362 | $34839 | |||
| BIOA BioAge Labs, Inc. - Common Stock | $2468941 | 1.14% | 100732 | 上涨 ×1 | |||
| LBRX LB Pharmaceuticals Inc - Common Stock | $2215021 | 1.02% | 68249 | 上涨 ×1 | |||
| EVMN Evommune, Inc. Common Stock | $1582347 | 0.73% | 119063 | $-2649261 | 下跌 ×2 | ||
| ACET Adicet Bio, Inc. - Common Stock | $1363625 | 0.63% | 157827 | $288823 | |||
| 无匹配项 | |||||||
最大新仓位
本季度新开仓位，按规模从大到小排序。
季度涨幅榜
已退出持仓
包含公司事件（合并、退市）——并非所有退出都是卖出
已关闭的头寸反映了 13F 报告的变更；对于指数管理人来说，这些通常是机械性的（退市、并购、指数再平衡），而不是主动决策。